<?xml version="1.0" encoding="UTF-8"?>
<p>Hepatitis C virus (HCV), an enveloped RNA virus, is a leading cause of chronic hepatitis, cirrhosis and liver cancer [
 <xref rid="jia225618-bib-0001" ref-type="ref">1</xref>]. In 2015, the global prevalence of chronic HCV infection was about 1%, affecting an equivalent of 71 million people, and with an estimated incidence of 1.75 million annually [
 <xref rid="jia225618-bib-0002" ref-type="ref">2</xref>]. HCV is primarily transmitted through bloodborne contacts, notably transfusion of contaminated blood or blood products, healthcare exposure to contaminated medical equipment and shared use of syringe among people who inject drugs (PWID) [
 <xref rid="jia225618-bib-0003" ref-type="ref">3</xref>]. In the last decade, accumulating cases of sexually acquired HCV infection suggested that high‐risk sexual behaviour has emerged to be a risk factor of increasing importance [
 <xref rid="jia225618-bib-0004" ref-type="ref">4</xref>, 
 <xref rid="jia225618-bib-0005" ref-type="ref">5</xref>].
</p>
